Home
Scientific Committee
Speakers
Program
Information
About
Contact
Submit Abstract
Register

Cardiovascular Pharmacology

Cardiovascular pharmacology: Cardiovascular pharmacology involves drugs that are used in the treatment of cardiovascular diseases. Many medications are used to treat various heart conditions. Some examples of the drugs used as cardiovascular medicine include:

Anticoagulants or blood thinners
Antiplatelet agents
Thrombolytic agents
Angiotensin-converting enzyme (ACE) inhibitors
Angiotensin II receptor blockers (ARBs)
Diuretics
Calcium channel blockers
Vasodilators
Digoxin

Related Sessions

1. Lipidology
2. Clinical Case Reports on Cardiology
3. Geriatric Cardiology
4. Current Research and Advances in Cardiology
5. Pediatric Cardiology
6. Rheumatic Heart Disease
7. Sudden Cardiac Arrest
8. Valvular Heart Disease
9. Sports Cardiology
10. Cardiovascular Imaging
11. Cardiovascular Regenerative Medicine
12. Arrhythmias and Electrophysiology
13. Preventative Cardiology and Public Health
14. Cardio-Oncology
15. Congenital Heart Diseases
16. Cardiovascular Pharmacology and Therapeutics
17. Interventional Cardiology
18. Cardiac Rehabilitation and Lifestyle Medicine
19. Metabolic and Systemic Heart Diseases
20. Coronary Artery and Vascular Diseases
21. Genetic and Inherited Heart Diseases
22. Heart Failure and Transplant Cardiology
23. Infections and Inflammatory Heart Diseases
24. Cardiovascular and Circulatory System Diseases
25. Metabolic and Lifestyle-Related Heart Diseases
26. Pulmonary Heart Diseases
27. Global Cardiovascular Challenges
28. Digital Cardiology and AI
29. Critical Care Cardiology
30. Structural Cardiology
31. Nanotechnology and Cardiovascular Medicine
32. Personalized Cardiology and Precision Medicine
33. Cardiomyopathies
34. Pericardial Diseases
35. Cardiovascular Complications in Other Diseases
36. Hypertensive Heart Diseases
37. Ischemic Heart Diseases

Scientific Program

Keynote Presentation (Virtual)

Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?

Yochai Birnbaum, Baylor College of Medicine, United States

View Profile HTML

Keynote Presentation (Virtual)

Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease

Uwe Peter Tigor, Auxilius Pharma, United States, United States

View Profile HTML

Keynote Presentation (Virtual)

Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms

Guo Wei He, Tianjin University, China

View Profile HTML

Keynote Presentation (Virtual)

Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease

Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation

View Profile HTML

Keynote Presentation (In-Person)

Title : New mechanisms and innovative therapeutics for pulmonary hypertension

Yong Xiao Wang, Albany Medical Center, United States

View Profile HTML

Oral Presentation (Virtual)

Title : Precision nutrition for heart health: A personalized approach to cardiovascular disease prevention and management

Teji Dhami, BOOST your Health and Wellness, United States

View Profile HTML

View Full Scientific Program

Committee Members

Yochai Birnbaum

Baylor College of Medicine, United States

Uwe Peter Tigor

Auxilius Pharma, United States, United States

Federico Benetti

Benetti Foundation, Argentina

View All Members

Cardio 2026 Speakers

Sergey Suchkov

Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation